Regulatory bodies like the FDA and EMA play a pivotal role in ensuring that new medications are safe for public use. They require comprehensive toxicological data before approving a drug. Post-market surveillance continues to monitor adverse effects, allowing for timely interventions if unforeseen toxicities arise.
